About Gufic BioSciences Ltd 
Gufic BioSciences Ltd
Small Cap
Pharmaceuticals & Biotechnology
Gufic Biosciences Limited is a prominent global pharmaceutical enterprise dedicated to delivering a broad spectrum of pharmaceutical services to its clients. Renowned for its extensive range of pharmaceutical products, Gufic operates as a comprehensive solution provider in both domestic and international markets, supported by a robust distribution network. The Company is ranked among the top 100 pharmaceutical companies in India.
Company Coordinates 
Company Details
Shop-37 1st Flr Kamala Bhavan, Swami Nityanand Road Andheri(E Mumbai Maharashtra : 400069
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Capital Structure 
Present Equity Capital
INR 10.03 Cr
Number of Shares
10.03 Cr
Face Value
INR 1.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
10-Oct-2023
10.03
10.03
3333000
1
Preferential Issue Of Shares
03-Jun-2021
9.69
9.69
19114506
1
Scheme of Amalgamation
08-Oct-2018
7.78
7.78
480000
1
Allotment of Equity To Others
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 5 Schemes (3.43%)
FIIs
Held by 25 FIIs (0.46%)
Promoter with highest holding
Jayesh Pannalal Choksi (24.62%)
Highest Public shareholder
Motilal Oswal Financial Services Ltd (3.32%)
Individual Investors Holdings
14.0%
Management
Designation
Remuneration
Jayesh P Choksi
Chairman & Managing Director
40.41 lacs
Pranav J Choksi
Whole Time Director & CEO
20.41 lacs
Pankaj Gandhi
Whole-time Director
14.33 lacs
Shreyas Patel
Non-Exec. & Independent Dir.
70.0 k
Ami Naresh Shah
Company Sec. & Compli. Officer
0
Gopal Daptari
Non-Exec. & Independent Dir.
70.0 k
Shrirang V Vadiya
Non-Exec. & Independent Dir.
70.0 k
Balram Singh
Non-Exec & Non-Independent Dir
0
Rabi Narayan Sahoo
Non-Exec. & Independent Dir.
50.0 k
Anusanjiv Aurora
Non-Exec. & Independent Dir.
70.0 k
Dilip Ghosh
Whole-time Director
20.98 lacs
Raw Materials Dashboard 
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Dashboard 
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
No Data Available for Finished Goods Segmentation
No Data Available
Revenue and Profits:
Net Sales:
261 Cr
(Quarterly Results - Jun 2026)
Net Profit:
22 Cr
Pharmaceuticals & Biotechnology
INR 4,377 Cr (Small Cap)
59.00
37
0.05%
0.49
9.66%
6.56






